Genetic Engineering & Biotechnology News

NOV15 2017

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link: http://gen.epubxp.com/i/896089

Contents of this Issue

Navigation

Page 34 of 37

For more information, visit our website (GENengnews.com), click on New Products, and search through our comprehensive new products database. New Products Genetic Engineering & Biotechnology News | GENengnews.com | NOVEMBER 15, 2017 | 33 People Clinical OMICs extends GEN's comprehensive coverage to the clinic by focusing on the application of revolutionary molecular technologies in medical practice. Topics covered include personalized and precision medicine, next-gen sequencing, bioinformatics, reimbursement, and bioethics. To see past issues, recent news, and subscribe, go to: clinicalomics.com GEN'S ePUB Molecular Diagnostics in Personalized Medicine Advanced Analytical . . . . . . . . . . . . . . . . . 10 BD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 Bethyl Laboratories . . . . . . . . . . . . . . . . . . 27 Big Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 BioSpec . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 Cambridge Healthtech Institute . . . . . . 21 Cayman Chemical . . . . . . . . . . . . . . . . . . . . 24 Clinical OMICs . . . . . . . . . . . . . . . . . . . . . . . 33 Eurofins . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 GEN/MilliporeSigma . . . . . . . . . . . . . . . . . 15 GEN/Mirus webinar . . . . . . . . . . . . . . . . . . 35 GEN/Bio-Techne webinar . . . . . . . . . . . . . 30 Infors HT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 Integra Biosciences . . . . . . . . . . . . . . . . . . 11 Labcyte . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 MaxCyte . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16 Mirus Bio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 OriGene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36 Promega . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5 Quanterix . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 Refine Technology . . . . . . . . . . . . . . . . . . . 13 Sonntek . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 Spectrum Labs . . . . . . . . . . . . . . . . . Cover Tip Advertiser Index Reprints Karen Ballen 914-740-2194 reprints@GENengnews.com GEN offers reprints of individual articles — in print- ed or electronic form — to increase awareness of your product or company. Order today! BiOasis Technologies ap- pointed Nancy Stagliano, Ph.D., Deborah Rathjen, Ph.D., and Maha Radhakrishnan, M.D., to its board of directors. Sorrento Therapeutics elected Dorman Followwill and Dave Lemus to its board of directors. Pliant Therapeutics appointed John Curnutte, M.D., Ph.D., to its board of directors and hired Katerina Leftheris, Ph.D., as vice president of chemistry. bluebird bio elected Mary Lynne Hedley, Ph.D., to its board of directors. Medicenna appointed William Li, M.D., to its board of directors. Nektar Therapeutics elected Jeff Ajer to its board of directors. Ascentage Pharma welcomed Yingjie (Jason) Huang, M.D., as senior vice president, clinical development. CTI BioPharma elected Laurent Fischer, M.D., as its new chairman of the board. NeRRe Therapeutics appointed Andrew Kay as chairman of its board of directors. Wendel Barr joined Vium as CEO. Sunquest Information Systems promoted Michael Epplen as president. BD appointed Timothy M. Ring and David F. Melcher to its board of directors. Kala Pharmaceuticals elected Andrew I. Koven to its board of directors. XBiotech appointed William Levis, M.D., to its scientific advisory board. BioMarin appointed Robert J. Hombach to its board of directors. Christophe Quéva, Ph.D., is the new CSO of Oncorus. Translate Bio appointed Danielle Beckman to its board of directors. Angelo Moesslang, Ph.D., is the new CEO of InGeneron. Zosano Pharma appointed Kenneth Greathouse to its board of directors. Classified - -- Mini Bead Beater 24 Tissue Tearor Mini Bead Beater 16 Mini Bead Beater 96 Bio Pulverizer Cryo Cup 800.617.3363 TUBE VORTEXER Bio Vortexer Send your People Announcements to people@GENengnews.com Rubius Therapeutics hired Chris Carpenter, M.D., Ph.D., as CMO. Dr. Carpenter most recently served as se- nior vice president and head of the cancer epigenetics department at Glaxo- SmithKline. Prior to that, he was director of clinical oncology at Merck. Profile Profile Andrea Bodnar, Ph.D., is the new science director of the Gloucester Marine Genomics Institute. Dr. Bodnar has held senior scientist positions at Hoffman-La Roche and Geron. She also held a senior scientist positon at the Bioprocessing Technology Institute at the National University of Singapore. Profile Subscribe Lothar Kappich, Ph.D., chairman of the board of Sartorius Stedim Biotech, was confirmed as the executor of Horst Sartorius' will. As such, he will control 50.1% of ordinary shares in the company. Dr. Kappich holds a degree in Economics and has been a member of the board since 2007.

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - NOV15 2017